Resilience and Ingenuity: Global Innovation Responses to Covid-19

Carsten Fink, Yann Ménière, Andrew A. Toole, Reinhilde Veugelers 13 July 2022





Carsten Fink, Yann Ménière, Andrew A. Toole and Reinhilde Veugelers

Part I: Impact across the world: Much similarity, some divergence

1 How the COVID-19 crisis affected international intellectual property filings
Carsten Fink, Ryan Lamb, Bruno Le Feuvre and Hao Zhou

2 Immunity to the COVID-19 shock? The case of US innovation
Walter G. Park, Andrew A. Toole, Gerard Torres and Richard D. Miller

3 Impact of the COVID-19 pandemic on trademark activity in Canada
Gray Barski, Alex Lehmann, Diego Santilli and Sean Martineau

4 COVID-19 and the analysis of patent, trademark and industrial design applications in Brazil
Marina Filgueiras Jorge, Sergio M Paulino de Carvalho, Irene von der Weid, Fernando Linhares de Assis, Gustavo Travassos and Vera Pinheiro

5 Impact of the COVID-19 pandemic on patent activity: Some evidence from patent filings at the European Patent Office
Bettina Reichl and Marc Nicolas

6 The impact of COVID-19 and Singapore’s response
William Kwek, Jia Yi Ho, Wei En Thong, Tan Chor Kiang, Muhammad Bin Rahmat and Benjamin Mak

7 The COVID-19 impact on innovation in China
Can Huang and Yurong Zhang

8 COVID-19: Crisis or opportunity? The case of South Korean innovation
Wonjoon Kim, Daehyun Kim and Taekyun Kim

9 Impacts of COVID-19 on R&D and patenting activities in Japan: Demand shocks, application delay, and patent option value
Isamu Yamauchi, Sadao Nagaoka and Daisuke Miyazaki

10 The COVID-19 impact in Australia
Michael Falk, Haiyang Zhang, Brodie Dobson-Keeffe, Catriona Bruce and Pushpika Wijesinghe

Part II: Responses in the innovation ecosystem

11 Impact of COVID-19 on investments in digital technologies by SMEs in the EU and the US
Julie Delanote, Ilja Rudyk and Désirée Rückert

12 The COVID-19 pandemic and academic research enterprise
Kyle R. Myers

13 The power of attention: Early indications of how the COVID-19 pandemic has affected the direction of scientific research in the life sciences
Karin Hoisl, Carolin Lerchenmüller, Marc Lerchenmueller and Leo Schmallenbach

14 COVID-19 and clinical trials
Margaret Kyle

15 The new mRNA breakthrough technology for vaccines: A lucky shot?
Reinhilde Veugelers

16 COVID and the US creative economy: Supply, demand, and the hastening of the future
Joel Waldfogel

17 Online consumption behaviour and how infringement levels changed during lockdown
UK Intellectual Property Office

18 The COVID-19 impact on artistic income: Evidence from Germany
Alexander Cuntz and Matthias Sahli

Chief Economist, World Intellectual Property Organization (WIPO)

Chief Economist, European Patent Office

Chief Economist, U.S. Patent and Trademark Office (USPTO)

Professor of Managerial Economics, Strategy and Innovation at the KULeuven and CEPR Research Fellow


CEPR Policy Research